Literature DB >> 17046253

Structure-activity relationships of the ultrapotent vanilloid resiniferatoxin (RTX): the homovanillyl moiety.

Giovanni Appendino1, Abdellah Ech-Chahad, Alberto Minassi, Sara Bacchiega, Luciano De Petrocellis, Vincenzo Di Marzo.   

Abstract

Starting from ROPA (2), analogues of RTX (1a) modified on the acyl side chain were prepared and evaluated for vanilloid activity in HEK-293 cells over-expressing the human recombinant TRPV1. The ROPA motif provided an enhancement of potency sufficient to expand the range of vanillyl surrogates to structural elements (e.g., an unsubstituted phenyl ring) that afford inactive analogues in compounds from the capsaicin series.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17046253     DOI: 10.1016/j.bmcl.2006.09.077

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  Receptor activity and conformational analysis of 5'-halogenated resiniferatoxin analogs as TRPV1 ligands.

Authors:  Kwang Su Lim; Dong Wook Kang; Yong Soo Kim; Myeong Seop Kim; Seul-Gi Park; Sun Choi; Larry V Pearce; Peter M Blumberg; Jeewoo Lee
Journal:  Bioorg Med Chem Lett       Date:  2010-11-05       Impact factor: 2.823

2.  Non-vanillyl resiniferatoxin analogues as potent and metabolically stable transient receptor potential vanilloid 1 agonists.

Authors:  Hyun-Kyung Choi; Sun Choi; Yoonji Lee; Dong Wook Kang; HyungChul Ryu; Han-Joo Maeng; Suk-Jae Chung; Vladimir A Pavlyukovets; Larry V Pearce; Attila Toth; Richard Tran; Yun Wang; Matthew A Morgan; Peter M Blumberg; Jeewoo Lee
Journal:  Bioorg Med Chem       Date:  2008-12-25       Impact factor: 3.641

3.  The carbonate analogues of 5'-halogenated resiniferatoxin as TRPV1 ligands.

Authors:  Kwang Su Lim; Hobin Lee; Sung Eun Kim; Tae-Hwan Ha; Jihyae Ann; Karam Son; Sun Choi; Wei Sun; Larry V Pearce; Ian A DeAndrea-Lazarus; Peter M Blumberg; Jeewoo Lee
Journal:  Eur J Med Chem       Date:  2013-08-09       Impact factor: 6.514

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.